Keyword: Infliximab


Pfizer Sues J&J over Arthritis Drug

03.10.2017 - Pfizer is suing Johnson & Johnson (J&J) in the US over what it terms anti-competitive practices against its biosimilar Inflectra. The lawsuit is said to be the first of its kind...


UK Watchdog Accuses Merck of Breaking Competition Law

25.05.2017 - The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...


EU Approves Pfizer-Hospira Deal With Strings

06.08.2015 - European regulatory authorities have approved the $15.2 billion takeover of injectable drug and infusion device maker Hospira by US drugmaker Pfizer, subject to certain conditions...